The Cancer Therapy &Research Center (CTRC) is led by Director, Ian M. Thompson, Jr., M.D. Dr. Thompson is assisted in this role by a Senior Leadership team, comprised of a Deputy Director and five Associate Directors, each of whom has expertise in their area of responsibility. They are: Tim H-M. Huang, Ph.D., Deputy Director;Karen Block, Ph.D., Associate Director for Shared Resources;Susan Padalecki, Ph.D., Associate Director for Research Administration;Amelie Ramirez, Dr. P.H., Associate Director for Cancer Prevention and Health Disparities;LuZhe Sun, Ph.D., Associate Director for Translational Research; and Steven Weitman, M.D., Ph.D., Associate Director for Clinical Research. The CTRC Senior Leadership team meets weekly with the Leaders of the CTRC Scientific Programs as an Executive Committee. One on one meetings with the Director and each other occur frequently as needed. Members of the Senior Leadership team provide counsel and recommendations to the Director based on these interactions and their interactions with the CTRC membership. Final authority for decisions on behalf of the CTRC resides with the Director. The Senior Leadership works directly with the Program Leaders, Shared Resource Directors, and other CTRC committees to build consensus on CTRC-wide priorities, strategies, and allocation of resources. The Senior Leaders ensure consistency in the mission, vision, and goals of the CTRC and develop synergistic interactions among the basic, translational, and clinical elements of the Center. They provide feedback on the growth and the needs of the CTRC in their area of responsibility. They also plan and implement proactive, integrative approaches for development of the research base, resources, and a formal strategic plan.

Public Health Relevance

Support is requested for the Senior Leadership of the Cancer Therapy &Research Center (CTRC). This leadership is critical to ensuring the overall success of the CTRC in fulfilling its mission and meeting its goals and in the strategic planning and evaluation of all CTRC efforts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-20
Application #
8758433
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M3))
Project Start
1997-08-01
Project End
2019-07-31
Budget Start
2014-09-16
Budget End
2015-07-31
Support Year
20
Fiscal Year
2014
Total Cost
$187,026
Indirect Cost
$39,732
Name
University of Texas Health Science Center
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Du, Liqin; Zhao, Zhenze; Suraokar, Milind et al. (2018) LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget 9:29601-29618
Ankerst, Donna P; Straubinger, Johanna; Selig, Katharina et al. (2018) A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol 74:197-203
Sun, Xiujie; Gupta, Kshama; Wu, Bogang et al. (2018) Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. J Biol Chem 293:2841-2849
Horning, Aaron M; Wang, Yao; Lin, Che-Kuang et al. (2018) Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response. Cancer Res 78:853-864
Gong, Siqi; Tomusange, Khamis; Kulkarni, Viraj et al. (2018) Anti-HIV IgM protects against mucosal SHIV transmission. AIDS 32:F5-F13
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21
Soteros, Breeanne M; Cong, Qifei; Palmer, Christian R et al. (2018) Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene. PLoS One 13:e0199399
Katti, Sachin; Her, Bin; Srivastava, Atul K et al. (2018) High affinity interactions of Pb2+ with synaptotagmin I. Metallomics 10:1211-1222
De La Chapa, Jorge J; Singha, Prajjal Kanti; Lee, Debbie R et al. (2018) Thymol inhibits oral squamous cell carcinoma growth via mitochondria-mediated apoptosis. J Oral Pathol Med 47:674-682
Wang, Zhonghua; Bhattacharya, Akash; White, Tommy et al. (2018) Functionality of Redox-Active Cysteines Is Required for Restriction of Retroviral Replication by SAMHD1. Cell Rep 24:815-823

Showing the most recent 10 out of 989 publications